BACKGROUND: Despite advances in preoperative staging, cancer of the pancreatic head is frequently found to be unresectable at laparotomy. We sought to identify potential areas of improvement in preoperative staging. METHODS: We performed a retrospective institutional review of patients referred for resection of cancer of the pancreatic head over a 2-year period. The primary outcome was the rate of metastasis or unresectable disease found at laparotomy in patients who were booked for pancreaticoduodenectomy with curative intent. RESULTS: During the study period, 133 patients were referred with suspected cancer of the pancreatic head. All underwent preoperative computed tomography scanning. Twenty-four also underwent preoperative endoscopic ultrasonography (EUS) and 23 also underwent magnetic resonance imaging (MRI). In total, 78 patients were deemed not to be candidates for surgery, leaving 55 patients with potentially resectable cancer who were scheduled for pancreaticoduodenectomy. Of these, 32 patients (58%) underwent successful resection with curative intent, and 23 patients (42%) were found to have metastatic or locally advanced disease not identified by preoperative staging. Reasons for nonresectability were metastases (9 patients, 16%), vascular involvement (12 patients, 22%) and mesentery involvement (2 patients, 4%). One patient had a diagnostic laparoscopy immediately before planned open exploration and was found to have peritoneal seeding precluding curative resection. Of the patients who underwent EUS, 14 were not surgical candidates because of locally advanced tumours. Ten patients were offered surgery with curative intent, and 5 patients (50%) were found have unresectable tumours (4 metastatic, 1 locally advanced). Of the patients who underwent MRI, 11 were offered surgery, and 5 (45%) had unresectable tumours (2 metastatic, 3 locally advanced disease). CONCLUSION: In our institution, preoperative staging for cancer of the pancreatic head misses a substantial number of metastatic and unresectable disease. There is clearly room for improvement, and newer technologies should be evaluated to enhance the detection of metastatic and locally advanced disease to prevent unnecessary laparotomy.
BACKGROUND: Despite advances in preoperative staging, cancer of the pancreatic head is frequently found to be unresectable at laparotomy. We sought to identify potential areas of improvement in preoperative staging. METHODS: We performed a retrospective institutional review of patients referred for resection of cancer of the pancreatic head over a 2-year period. The primary outcome was the rate of metastasis or unresectable disease found at laparotomy in patients who were booked for pancreaticoduodenectomy with curative intent. RESULTS: During the study period, 133 patients were referred with suspected cancer of the pancreatic head. All underwent preoperative computed tomography scanning. Twenty-four also underwent preoperative endoscopic ultrasonography (EUS) and 23 also underwent magnetic resonance imaging (MRI). In total, 78 patients were deemed not to be candidates for surgery, leaving 55 patients with potentially resectable cancer who were scheduled for pancreaticoduodenectomy. Of these, 32 patients (58%) underwent successful resection with curative intent, and 23 patients (42%) were found to have metastatic or locally advanced disease not identified by preoperative staging. Reasons for nonresectability were metastases (9 patients, 16%), vascular involvement (12 patients, 22%) and mesentery involvement (2 patients, 4%). One patient had a diagnostic laparoscopy immediately before planned open exploration and was found to have peritoneal seeding precluding curative resection. Of the patients who underwent EUS, 14 were not surgical candidates because of locally advanced tumours. Ten patients were offered surgery with curative intent, and 5 patients (50%) were found have unresectable tumours (4 metastatic, 1 locally advanced). Of the patients who underwent MRI, 11 were offered surgery, and 5 (45%) had unresectable tumours (2 metastatic, 3 locally advanced disease). CONCLUSION: In our institution, preoperative staging for cancer of the pancreatic head misses a substantial number of metastatic and unresectable disease. There is clearly room for improvement, and newer technologies should be evaluated to enhance the detection of metastatic and locally advanced disease to prevent unnecessary laparotomy.
Authors: Shandra Bipat; Saffire S K S Phoa; Otto M van Delden; Patrick M M Bossuyt; Dirk J Gouma; Johan S Laméris; Jaap Stoker Journal: J Comput Assist Tomogr Date: 2005 Jul-Aug Impact factor: 1.826
Authors: Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro Journal: Am J Gastroenterol Date: 2004-03 Impact factor: 10.864
Authors: Rebekah White; Corrine Winston; Mithat Gonen; Michael D'Angelica; William Jarnagin; Yuman Fong; Kevin Conlon; Murray Brennan; Peter Allen Journal: J Am Coll Surg Date: 2007-11-26 Impact factor: 6.113
Authors: Antonino Spinelli; Daniele Del Fabbro; Matteo Sacchi; Alessandro Zerbi; Guido Torzilli; Fabio R Lutman; Luigi Laghi; Alberto Malesci; Marco Montorsi Journal: World J Surg Date: 2011-11 Impact factor: 3.352
Authors: Robert de W Marsh; Mark S Talamonti; Marshall S Baker; Mitchell Posner; Kevin Roggin; Jeffrey Matthews; Daniel Catenacci; Mark Kozloff; Blase Polite; Michele Britto; Chi Wang; Hedy Kindler Journal: J Surg Oncol Date: 2017-10-16 Impact factor: 3.454
Authors: Haoming Qiu; Aaron T Wild; Hao Wang; Elliot K Fishman; Ralph H Hruban; Daniel A Laheru; Rachit Kumar; Amy Hacker-Prietz; Richard Tuli; Erik Tryggestad; Richard D Schulick; John L Cameron; Barish H Edil; Timothy M Pawlik; Christopher L Wolfgang; Joseph M Herman Journal: Radiother Oncol Date: 2012-08-08 Impact factor: 6.280
Authors: Paul D James; Zhao Wu Meng; Mei Zhang; Paul J Belletrutti; Rachid Mohamed; William Ghali; Derek J Roberts; Guillaume Martel; Steven J Heitman Journal: PLoS One Date: 2017-03-20 Impact factor: 3.240